MAR 21, 2023
By University of Edinburgh
The University of Edinburgh is awarding 12 scholarships to support international applicants accepted into their online Master of Surgery (ChM) in Clinical Ophthalmology program, thanks to the generous support of The David and Molly Pyott Foundation.
Ophthalmology trainees and qualified early-career ophthalmologists from Africa, Central and South Asia, Caribbean Islands, Pacific Islands, or Central and Latin America who are accepted for admission to the program are eligible to apply for the scholarship award, which will cover all tuition fees as well as internet access and a laptop. The deadline for scholarship applications is Thursday, June 1, 2023, at 23:59 DST.
The part-time, online 2-year ChM program is offered by the University of Edinburgh in partnership with the Royal College of Surgeons of Edinburgh and is designed to provide advanced education for those preparing for the fellowship examinations of the Royal College of Surgeons of Edinburgh (RCSEd) and the Royal College of Ophthalmologists (RCOphth), and those approaching consultancy.
Further program information is available online, along with an introductory video by Baljean Dhillon, professor of clinical ophthalmology at the University of Edinburgh and chair of RCSEd's Ophthalmology Speciality Advisory Committee, and video testimonials by ChM graduates. The ChM is one of several online masters programs in the surgical specialties delivered by the university in partnership with RCSEd. Applications for admission to the ChM program close on August 25.
The David and Molly Pyott Foundation has been funding this highly successful scholarship award in partnership with the university since 2016. The initiative has helped trainees and qualified ophthalmologists from a range of developing countries obtain a masters level education as part of their journey to becoming consultant/specialist ophthalmologists. The online, part-time nature of the ChM means that students can study at home without taking time out of practice or training, while continuing to deliver critical care in their regions.